WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 201

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 201

Item

http://www.wikidata.org/entity/Q34295635

Q34295635

about

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013 The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions.Incorporation of a proteotyping approach using mass spectrometry for surveillance of influenza virus in cell-cultured strains.Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine.Strain-specific antiviral activity of iminosugars against human influenza A viruses Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.Origin, distribution, and potential risk factors associated with influenza A virus in swine in two production systems in Guatemala.Viral aetiology influenza like illnesses in Santa Cruz, Bolivia (2010-2012)Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.Integrating influenza antigenic dynamics with molecular evolution Genetic mutations in influenza H3N2 viruses from a 2012 epidemic in Southern China.The contrasting phylodynamics of human influenza B viruses.Emerging, evolving, and established infectious diseases and interventions Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013.Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.Selection of antigenically advanced variants of seasonal influenza viruses.Influenza B vaccine lineage selection--an optimized trivalent vaccine.Age-specific genetic and antigenic variations of influenza A viruses in Hong Kong, 2013-2014.DNA vaccines: roles against diseases.Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach Influenza vaccines: from whole virus preparations to recombinant protein technology.Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015.Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology.Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies.Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes.Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus

P2860

Q27683640-FE5CFD67-2B7E-46EA-AE11-92B40A60631F Q28534776-22A8198D-AFDA-4E63-B211-1F749C70F66D Q28543158-7B175437-6018-4C03-B6E6-30E74BAE926E Q30205724-B78BB091-31F7-4C16-AE2F-0A81B4A73DFC Q30354277-B50B829E-6132-4311-80CD-7EEC760BD3C1 Q30355569-1F2619FA-0A02-4BE9-92A8-BE11D9C233F2 Q30364462-06E29252-C474-4E08-8940-AB667D69B1A2 Q30366818-9F713C3B-0A9F-42C7-AA06-8A8DB0321A3D Q30378860-A273D089-EB9C-498C-A316-F63033D71079 Q30395347-752BA93A-6676-40C8-8022-3576391961E5 Q33588689-2D1CCCB8-FB68-458D-B080-8CF9082202D5 Q33727940-83EBFD6C-8603-4D6A-A669-DFDAD2F637FD Q34039764-48113A2E-6B04-4231-B845-C406D90656D0 Q34464053-C882AB48-F39E-4C60-8301-F6AD9EF9122F Q35249640-EBDE22E4-D455-446A-B676-1C9CD0AB93CC Q35534867-ADC128A8-2CB6-47B7-92AA-A48103AD8F9C Q35761077-9106B4BA-2624-4F29-97C3-874808DF2B64 Q35983371-9142CBE0-236B-4EF0-A5AF-E7660BA1728C Q36116332-3F441A79-15C2-40ED-8D42-CB8A0EA9D74A Q36690569-98CABBC0-E9D2-4F48-8472-61BF08BEDBE4 Q37121810-E4861440-E033-4AAA-A260-CEBF6E831B89 Q37441566-B8A937D2-119E-40C1-A354-80A312380C21 Q37582475-E40D6CFD-6521-45D3-9ECC-6F391B4BA07A Q38160083-D97F9515-697D-4B11-846F-AFCF1BD50E0E Q38406947-F5384FB7-BA91-4952-A34C-72EC9F46FE56 Q40670577-87440F8B-C9D7-47C3-95A9-55B8715A7747 Q45323600-6DD6EDB8-A892-4BC8-B63B-B566E295C55B Q45951581-82C65E8B-E157-4E0E-96E5-F22E7FD90E64 Q47156080-531D9FA3-7A18-4A15-8685-7B239CE63A74 Q50420352-BD22B3DA-7DB2-4B15-B186-B568CE9D7883 Q54255837-0D322299-A531-4B86-B32D-23DD30F78E8D Q57094454-7ADDF88D-4F5E-4C03-8992-E3BC9615C9AC

P2860

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 201

Item

http://www.wikidata.org/entity/Q34295635

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu